GSA CAPITAL PARTNERS LLP - SINOVAC BIOTECH LTD ownership

SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 37 filers reported holding SINOVAC BIOTECH LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of SINOVAC BIOTECH LTD
ValueSharesWeighting
Q1 2016$155,000
+146.0%
24,200
+118.0%
0.01%
+233.3%
Q4 2015$63,000
-8.7%
11,100
-15.8%
0.00%
-40.0%
Q4 2014$69,000
-77.9%
13,186
-79.7%
0.01%
-68.8%
Q3 2014$312,000
+62.5%
64,800
+90.6%
0.02%
+77.8%
Q2 2014$192,00034,0000.01%
Other shareholders
SINOVAC BIOTECH LTD shareholders Q2 2016
NameSharesValueWeighting ↓
Verity Asset Management, Inc. 35,884$188,0000.17%
Orbimed Advisors 2,667,500$14,004,0000.10%
Freedom Investment Management, Inc. 157,295$826,0000.08%
Pine River Capital Management L.P. 1,095,041$5,749,0000.06%
FIRST MANHATTAN CO. LLC. 603,666$3,169,0000.02%
FIL Ltd 1,091,500$5,730,0000.02%
Renaissance Technologies 1,263,200$6,632,0000.02%
Zurcher Kantonalbank (Zurich Cantonalbank) 179,899$944,0000.01%
WELLINGTON MANAGEMENT GROUP LLP 4,068,406$21,359,0000.01%
ProShare Advisors LLC 44,592$234,0000.00%
View complete list of SINOVAC BIOTECH LTD shareholders